Low VLDL causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 33: | Line 33: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Cilostazol]], [[clofibrate]], [[colestyramine]], [[doxazosin]], [[nicotinic acid]], [[prazosin]], [[probucol]], [[statins]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 53: | Line 53: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[cystic fibrosis]], [[PCSK9#PCSK9 Deficiency|deficiency of proprotein convertase subtilisin-like/kexin type 9 | |bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[cystic fibrosis]], [[PCSK9#PCSK9 Deficiency|deficiency of proprotein convertase subtilisin-like/kexin type 9]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia|hyperlipoproteinemia, familial type 5]], [[hypobetalipoproteinemia]], [[lipoprotein lipase deficiency]], [[Abetalipoproteinemia|mutations of the MTTP gene]], [[Shwachman-Diamond syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 65: | Line 65: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[Giardiasis]] | |bgcolor="Beige"| [[Giardiasis]], [[Hepatitis C]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 77: | Line 77: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia|hyperlipoproteinemia, familial type 5]], [[hypobetalipoproteinemia]], [[lipoprotein lipase deficiency]], [[Abetalipoproteinemia|mutations of the MTTP gene]] | |bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia|hyperlipoproteinemia, familial type 5]], [[hypobetalipoproteinemia]], [[lipoprotein lipase deficiency]], [[Abetalipoproteinemia|mutations of the MTTP gene]], [[omega-3 fatty acid|omega-3 polyunsaturated fatty acids]], [[fish oil]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 142: | Line 142: | ||
*[[Chronic liver disease]] | *[[Chronic liver disease]] | ||
*[[Chronic pancreatitis]] | *[[Chronic pancreatitis]] | ||
*[[Cilostazol]]<ref name="pmid24139096">{{cite journal| author=Kim HJ, Moon JH, Kim HM, Yun MR, Jeon BH, Lee B et al.| title=The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression. | journal=Metabolism | year= 2013 | volume= | issue= | pages= | pmid=24139096 | doi=10.1016/j.metabol.2013.09.006 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24139096 }} </ref> | |||
*[[Cirrhosis]] | *[[Cirrhosis]] | ||
*[[Clofibrate]] | *[[Clofibrate]] | ||
| Line 156: | Line 157: | ||
*[[Familial hypobetalipoproteinemia]] | *[[Familial hypobetalipoproteinemia]] | ||
*[[Giardiasis]] | *[[Giardiasis]] | ||
*[[Hepatitis C]]<ref name="pmid24188401">{{cite journal| author=Rojas A, Del Campo JA, Maraver M, Aparcero R, García-Valdecasas M, Diago M et al.| title=Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro. | journal=J Viral Hepat | year= 2013 | volume= | issue= | pages= | pmid=24188401 | doi=10.1111/jvh.12209 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24188401 }} </ref> | |||
*[[Hyperlipoproteinemia|Hyperlipoproteinemia, familial type 5]] | *[[Hyperlipoproteinemia|Hyperlipoproteinemia, familial type 5]] | ||
*[[Hypobetalipoproteinemia]] | *[[Hypobetalipoproteinemia]] | ||
Revision as of 17:29, 8 November 2013
|
Very Low Density Lipoprotein Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Low VLDL causes On the Web |
|
American Roentgen Ray Society Images of Low VLDL causes |
|
Directions to Hospitals Treating Very low density lipoprotein |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Inherited disorders of lipoprotein metabolism like Abetalipoproteinemia and lipid lowering medications and diet are usually associated with low VLDL levels.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Scanu, AM.; Aggerbeck, LP.; Kruski, AW.; Lim, CT.; Kayden, HJ. (1974). "A study of the abnormal lipoproteins in abetalipoproteinemia". J Clin Invest. 53 (2): 440–53. doi:10.1172/JCI107578. PMID 11344558. Unknown parameter
|month=ignored (help) - ↑ Welty, FK.; Mittleman, MA.; Wilson, PW.; Sutherland, PA.; Matheney, TH.; Lipinska, I.; Muller, JE.; Levy, D.; Tofler, GH. (1997). "Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population". Circulation. 95 (4): 825–30. PMID 9054738. Unknown parameter
|month=ignored (help) - ↑ Kim HJ, Moon JH, Kim HM, Yun MR, Jeon BH, Lee B; et al. (2013). "The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression". Metabolism. doi:10.1016/j.metabol.2013.09.006. PMID 24139096.
- ↑ Rojas A, Del Campo JA, Maraver M, Aparcero R, García-Valdecasas M, Diago M; et al. (2013). "Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro". J Viral Hepat. doi:10.1111/jvh.12209. PMID 24188401.